drugset / Trial / NCT02132689
Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism
Phase 4
Completed
100 enrolled
University Hospital Ostrava
Municipal Hospital Ostrava Fifejdy · collabSilesian Hospital Opava · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Currently there is no clear guidance for the treatment of moderate risk of pulmonary embolism. The aim of the study is to compare two different therapeutic modalities - standard anticoagulation versus thrombolytic treatment followed by anticoagulation in standard regimen as stated in the pulmonary embolism guidelines.
Timeline
- Start
- 2011-03
- Primary completion
- 2015-05
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alteplase | Protein / enzyme biologic | — | — |
| Comparator | Heparin | Other / unclassified | — | — |